...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

Well I own ZHCLF (bought on the open market OTC) and now I am able to and have voted in the Zenith Capital Corp (Calgary) Annual & Speical Meeting.  I guess this confirms that ZHCLF is in fact shares of ZCC (Calgary) (Zenith Epigenetics).

Share
New Message
Please login to post a reply